2UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. ( UKPDS 33) Lancet 1998:352: 837- 853.
3Moses R, Slobodnivk R, Boyages S, et al. Elect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 1999 ;22 :119-124 .
5Smedegaard kristensen J, Brown Fraudsen K, Bayer T, et al. Repaglinide treatment is associated with significantly less severe hypoglycaelnic events compared to sulphonylureas. Diabetologia 1999 ; 4 (Suppl. 1) : A4.
6Nattrass M, Lauritzen T. Review of Prandial glucose regulation with repalinide:a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? lnt J Obes Relat Metab Disord 2000;24(Suppl. 33):S21-31.
7Kvapil M,Swatko A,Hilberg C,Shestakova M.Biphasic insulin aspart 30 plus metformin:an effective combination in type 2 diabetes.Diabetes obes metab 2006;8(1):39-48.
8Fukui M,Nakano K,Shigeta H,et al.Anti-bodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycaemic therapy[J].Diabet Med,1997,14(2):148-152.
